TransPharma Medical Report issue

For profit Phase 1 Phase 2
Founded: Lod Israel (2000)
Status: Acquired by Syneron Medical (2012) → now Apax Partners (2017)

Organization Overview

First Clinical Trial
2007
NCT00455260
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

TransPharma-Medical Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

teriparatide (2 trials)

Drugs in Phase 1 Trials (1)

somatropin (protropin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dwarfism, Pituitary (Phase 1)

Osteoporosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2